Anaesthesia, surgery, and life-threatening allergic reactions: epidemiology and clinical features of perioperative anaphylaxis in the 6th National Audit Project (NAP6)

British Journal of Anaesthesia

Volumn 121, Issue 1, 2018, Pages 159-171

  Harper, N J N ^a,b,c   Cook, T M ^c,d,e   Garcez, T ^a   Farmer, L ^c   Floss, K ^f   Marinho, S ^a   Torevell, H ^t   Warner, A ^g   Ferguson, K ^h   Hitchman, J ^c   Egner, W ^i,j   Kemp, H ^k   Thomas, M ^l   Lucas, D N ^m   Nasser, S ⁿ   Karanam, S ^o   Kong, K L ^o   Farooque, S ^p   Bellamy, M ^q,r   McGuire, N ^s  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c ROYAL COLLEGE OF ANAESTHETISTS   (United Kingdom)

^d ROYAL UNITED HOSPITAL   (United Kingdom)

^e UNIVERSITY OF BRISTOL   (United Kingdom)

^f OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^g Allergy UK (Allergy UK)   (United Kingdom)

^h ABERDEEN ROYAL INFIRMARY   (United Kingdom)

ⁱ SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^j UNIVERSITY OF SHEFFIELD   (United Kingdom)

^k IMPERIAL COLLEGE LONDON   (United Kingdom)

^l GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^m NORTHWICK PARK HOSPITAL   (United Kingdom)

ⁿ CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^o SANDWELL AND WEST BIRMINGHAM HOSPITALS NHS TRUST   (United Kingdom)

^p IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^q LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^r UNIVERSITY OF LEEDS   (United Kingdom)

^s MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY   (United Kingdom)

^t Medicines and Healthcare products Regulatory Agency ^*

more..

Author keywords

allergy; anaesthesia; anaphylaxis; National Audit Project

Indexed keywords

ACETYLSALICYLIC ACID; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; APROTININ; ATRACURIUM BESILATE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BLOOD DERIVATIVE; CEFUROXIME; CHLORHEXIDINE; CISATRACURIUM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DISULFINE BLUE; FLUCLOXACILLIN; GELATIN; GENTAMICIN; HEPARIN; IBUPROFEN; METRONIDAZOLE; MIVACURIUM; NEUROMUSCULAR BLOCKING AGENT; ONDANSETRON; PANCURONIUM; PIPERACILLIN PLUS TAZOBACTAM; PROPOFOL; PROTAMINE; ROCURONIUM; SUGAMMADEX; SUXAMETHONIUM; TEICOPLANIN; VANCOMYCIN;

ANAPHYLAXIS; ANESTHESIA; ARTICLE; BRADYCARDIA; BRONCHOSPASM; CAPNOMETRY; CLINICAL AUDIT; CLINICAL FEATURE; CYANOSIS; DRUG FATALITY; HEART ARREST; HUMAN; HYPOTENSION; INCIDENCE; LARYNX EDEMA; LIFE THREAT; MAJOR CLINICAL STUDY; MORTALITY; NAUSEA; OBESITY; OUTCOME ASSESSMENT; OXYGEN DESATURATION; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PRURITUS; PULSE WAVE; RASH; STRIDOR; SURGERY; TACHYCARDIA; UNITED KINGDOM; URTICARIA; VOMITING; ADOLESCENT; ADULT; AGED; CHILD; DRUG HYPERSENSITIVITY; FEMALE; INFANT; MALE; MIDDLE AGED; NEWBORN; PATHOPHYSIOLOGY; PRESCHOOL CHILD; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANAPHYLAXIS; ANESTHESIA; CHILD; CHILD, PRESCHOOL; DRUG HYPERSENSITIVITY; FEMALE; HEART ARREST; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MEDICAL AUDIT; MIDDLE AGED; PERIOPERATIVE PERIOD; SURGICAL PROCEDURES, OPERATIVE; UNITED KINGDOM; YOUNG ADULT;

EID: 85047228150     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1016/j.bja.2018.04.014     Document Type: Article

References (54)

1. Johansson, S.G., Hourihane, J.O., Bousquet, J., et al. A revised nomenclature for allergy. An EEACI position statement from the EEACI nomenclature task force. Allergy 56 (2001), 813–824.
2. Hepner, D.L., Castells, M.C., Anaphylaxis during the perioperative period. Anesth Analg 97 (2003), 1381–1395.
3. Mertes, P.M., Alla, F., Tréchot, P., et al. Anaphylaxis during anesthesia in France: an 8-year national survey. J Allergy Clin Immunol 128 (2011), 366–373.
4. Savic, L., Kaura, V., Yusaf, M., et al. Incidence of suspected perioperative anaphylaxis: a multicentre snapshot study. J Allergy Clin Immunol Pract, 3, 2015 454–455.e1.
5. Low, A.E., McEwan, J.C., Karanam, S., North, J., Kong, K.L., Anaesthesia-associated hypersensitivity reactions: seven years’ data from a British bi-specialty clinic. Anaesthesia 71 (2016), 76–84.
6. Kroigaard, M., Garvey, L.H., Gillberg, L., et al. Scandinavian clinical practice guidelines on the diagnosis, management and follow-up of anaphylaxis during anaesthesia. Acta Anaesthesiol Scand 51 (2007), 655–670.
7. Harper, N.J.N., Dixon, T., Dugue, P., et al. Guidelines suspected anaphylactic reactions associated with anaesthesia. Anaesthesia 64 (2009), 199–211.
8. Kolawole, H., Marshall, S., Crilly, H., Kerridge, R., Roessler, P., Australian and New Zealand Anaesthetic Allergy Group/Australian and New Zealand College of Anaesthetists Perioperative Anaphylaxis Management Guidelines. Anaesth Intensive Care 45 (2017), 151–158.
9. Parkes, A.W., Harper, N., Herwadkar, A., Pumphrey, R., Anaphylaxis to the chlorhexidine component of Instillagel: a case series. Br J Anaesth 102 (2009), 65–68.
10. Egner, W., Helbert, M., Sargur, R., et al. Chlorhexidine allergy in four specialist allergy centres in the United Kingdom, 2009–13: clinical features and diagnostic tests. Clin Exp Immunol 188 (2017), 380–386.
11. Mertes, P.M., Malinovsky, J.M., Mouton-Faivre, C., et al. Anaphylaxis to dyes during the perioperative period: reports of 14 clinical cases. J Allergy Clin Immunol 122 (2008), 348–352.
12. Cook, T.M., Harper, N.J.N., Farmer, L., et al. Anaesthesia, surgery and life-threatening allergic reactions: protocol and methods of the 6th National Audit Project (NAP6) of the Royal College of Anaesthetists. Br J Anaesth 121 (2018), 124–133.
13. Kemp, H., Marinho, S., Cook, T.M., et al. A cross-sectional study of anaesthetic workload in the United Kingdom in 2016: the NAP6 Activity Survey. Br J Anaesth, 2018 In press.
14. Marinho, S., Kemp, H., Cook, T.M., et al. A cross-sectional study of anaesthetic drug exposure in United Kingdom practice. The NAP6 Allergen Survey. Br J Anaesth, 2018 In press.
15. Harper, N.J.N., Cook, T.M., Garcez, T., et al. Anaesthesia, surgery and life-threatening allergic reactions: management, outcomes and recommendations in the 6th National Audit Project (NAP6) of the Royal College of Anaesthetists. Br J Anaesth 121 (2018), 172–188.
16. Pumphrey, R.S.H., Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy 30 (2000), 1144–1150.
17. Harboe, T., Guttormsen, A.B., Irgens, A., Dybendal, T., Florvaag, E., Anaphylaxis during anesthesia in Norway: a 6-year single-center follow-up study. Anesthesiology 102 (2005), 897–903.
18. Leysen, J., De Witte, L., Bridts, C.H., Ebo, D.G., Anaphylaxis during general anaesthesia: a 10-year survey 1 at the University Hospital of Antwerp. P Belg Royal Acad Med 2 (2013), 88–100.
19. National Institute for Health and Clinical Excellence. CG 183, Drug allergy: diagnosis and management of drug allergy in adults, children and young people. 2014, 1–167 https://www.nice.org.uk/guidance/CG183. [Accessed 3 May 2018].
20. Macy, E., Contreras, R., Health care use and serious infection prevalence associated with penicillin ‘allergy’ in hospitalized patients: a cohort study. J Allergy Clin Immunol 133 (2014), 790–796.
21. SadeI, K., Holtzer, Y., Levo, Y., Kivity, S., The economic burden of antibiotic treatment of penicillin-allergic patients in internal medicine wards of a general tertiary care hospital. Clin Exp Allergy 33 (2003), 501–506.
22. Solensky, R., Penicillin allergy as a public health measure. J Allergy Clin Immunol 133 (2014), 797–798.
23. Kemp, H.I., Cook, T.M., Thomas, M., Harper, N.J.N., UK anaesthetists’ perspectives and experiences of severe perioperative anaphylaxis: NAP6 baseline survey. Br J Anaesth 119 (2017), 132–139.
24. Mertes, P.M., Laxenaire, M.-C., Alla, F., Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999–2000. Anesthesiology 99 (2003), 536–545.
25. Baldo, B.A., Fisher, M.M., Pham, N.H., On the origin and specificity of antibodies to neuromuscular blocking (muscle relaxant) drugs: an immunochemical perspective. Clin Exp Allergy 39 (2009), 325–344.
26. Didier, A., Cador, D., Bongrand, P., et al. Determinants in allergy to muscle relaxants. J Allergy Clin Immunol 79 (1987), 578–584.
27. Johansson, S.G.O., Florvaag, E., Öman, H., et al. National pholcodine consumption and prevalence of IgE-sensitization: a multicentre study. Allergy 65 (2010), 498–502.
28. de Pater, G., Florvaag, E., Johansson, S., Irgens, A., Petersen, M., Guttormsen, A., Six years without pholcodine; Norwegians are significantly less IgE-sensitized and clinically more tolerant to neuromuscular blocking agents. Allergy 72 (2017), 813–819.
29. McNeil, B.D., Pundir, P., Meeker, S., et al. Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions. Nature 519 (2014), 237–241.
30. Reddy, J.I., Cooke, P.J., Van Schalkwyk, J.M., Hannam, J.A., Fitzharris, P., Mitchell, S.J., Anaphylaxis is more common with rocuronium and succinylcholine than with atracurium. Anesthesiology 122 (2015), 39–45.
31. Sadleir, P.H.M., Clarke, R.C., Bunning, D.L., Platt, P.R., Myles, P.S., Anaphylaxis to neuromuscular blocking drugs: incidence and cross-reactivity in Western Australia from 2002 to 2011. Br J Anaesth 110 (2013), 981–987.
32. Laake, J.H., Rottingen, J.A., Rocuronium and anaphylaxis—a statistical challenge. Acta Anaesthesiol Scand 45 (2001), 1196–1203.
33. Egner, W., Cook, T.M., Harper, N., et al. Specialist perioperative allergy clinic services in the UK 2016: results from the Royal College of Anaesthetists Sixth National Audit Project. Clin Exp Allergy 47 (2017), 1318–1330.
34. Ebo, D.G., Bridts, C.H., Stevens, W.J., Anaphylaxis to an urethral lubricant: chlorhexidine as the ‘hidden’ allergen. Acta Clin Belg 59 (2004), 358–360.
35. Krishna, M., York, M., Chin, T., et al. Multi-centre retrospective analysis of anaphylaxis during general anaesthesia in the United Kingdom: aetiology and diagnostic performance of acute serum tryptase. Clin Exp Immunol 178 (2014), 399–404.
36. Opstrup, M., Malling, H., Krøigaard, M., et al. Standardized testing with chlorhexidine in perioperative allergy: a large single-centre evaluation. Allergy 69 (2014), 1390–1396.
37. Mertes, P.M., Volcheck, G.W., Garvey, L.H., et al. Epidemiology of perioperative anaphylaxis. Presse Med 45 (2016), 758–767.
38. Garvey, L.H., Krøigaard, M., Poulsen, L.K., et al. IgE-mediated allergy to chlorhexidine. J Allergy Clin Immunol 120 (2007), 409–415.
39. Nakonechna, A., Dore, P., Dixon, T., et al. Immediate hypersensitivity to chlorhexidine is increasingly recognised in the United Kingdom. Allergol Immunopathol (Madr) 42 (2014), 44–49.
40. Garvey, L.H., Roed-Petersen, J., Husum, B., Anaphylactic reactions in anaesthetised patients—four cases of chlorhexidine allergy. Acta Anaesthesiol Scand 45 (2001), 1290–1294.
41. Medicines and Healthcare Products Regulatory Agency, All medical devices and medical products containing chlorhexidine—risk of anaphylactic reaction due to chlorhexidine allergy. 2012 https://www.gov.uk/drug-device-alerts/medical-device-alert-all-medical-devices-and-medicinal-products-containing-chlorhexidine-risk-of-anaphylactic-reaction-due-to-chlorhexidine-allergy. [Accessed 3 May 2018].
42. Barthelmes, L., Goyal, A., Newcombe, R.G., McNeill, F., Mansel, R.E., Adverse reactions to Patent Blue V dye—the NEW START and ALMANAC experience. Eur J Surg Oncol 36 (2010), 399–403.
43. Brenet, O., Lalourcey, L., Queinnec, M., et al. Hypersensitivity reactions to Patent Blue V in breast cancer surgery: a prospective multicentre study. Acta Anaesthesiol Scand 57 (2013), 106–111.
44. Hunting, A.S., Nopp, A., Johansson, S.G.O., Andersen, F., Wilhelmsen, V., Guttormsen, A.B., Anaphylaxis to Patent Blue V. I. Clinical aspects. Allergy 65 (2010), 117–123.
45. Ishiyama, T., Kotoda, M., Asano, N., et al. The effects of Patent Blue dye on peripheral and cerebral oxyhaemoglobin saturations. Anaesthesia 70 (2015), 429–433.
46. Takahashi, Y., Hara, K., Sata, T., A case of prolonged reduction in arterial oxygen saturation measured by pulse oxymetry after administering Patent Blue in an elderly patient. Masui 62 (2013), 422–424.
47. Murakami, T., Kayo, R., Kajita, I., Cho, S., Saito, H., False decrease in pulse oximetry readings due to Patent Blue in a patient with breast cancer. Masui 52 (2003), 909–911.
48. Serious Hazards of transfusion (SHOT). https://www.shotuk.org/.
49. Ouni, B., Bensayed, N., Fathallah, N., Slim, R., Regaieg, H., Fatal anaphylactic reaction to intravenous infusion of ondansetron: a report of two cases. Eur J Anaesthesiol 33 (2016), 140–155.
50. Asserhøj, L.L., Mosbech, H., Krøigaard, M., Garvey, L.H., Absalom, A.R., No evidence for contraindications to the use of propofol in adults allergic to egg, soy or peanut. Br J Anaesth 116 (2016), 77–82.
51. Harper, N.J.N., Propofol and food allergy. Br J Anaesth 116 (2016), 11–13.
52. Stewart, W.J., McSweeney, S.M., Kellett, M.A., Faxon, D.P., Ryan, T.J., Increased risk of severe protamine reactions in NPH insulin-dependent diabetics undergoing cardiac catheterization. Circulation 70 (1984), 788–792.
53. Kowalski, M.L., Asero, R., Bavbek, S., et al. Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs. Allergy 68 (2013), 1219–1232.
54. Mahajan, R.P., Critical incident reporting and learning. Br J Anaesth 105 (2010), 69–75.